Ompekimig, CAS 2981477-39-6

Product Description: Ompekimig is a humanized immunoglobulin monoclonal antibody targeting human interleukin 4 (IL-4) and interleukin 13 (IL-13). Ompekimig is promising for research of immune-mediated inflammatory diseases, such as asthma and atopic dermatitis[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

CAS Number: 2981477-39-6

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Target: Interleukin Related

• Artikelnummer: MEXHY-P991150-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991150-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated